Caricamento...
The clinical utility of circulating tumour cells in patients with small cell lung cancer
Small cell lung cancer (SCLC) accounts for 15% of lung cancer diagnosed worldwide. It is aggressive and characterised by early metastatic spread with rapid development of chemo resistance such that less than 5% of patients diagnosed survive 5 years. Surgery is rarely performed and failure to identif...
Salvato in:
| Pubblicato in: | Transl Lung Cancer Res |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AME Publishing Company
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5583068/ https://ncbi.nlm.nih.gov/pubmed/28904885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2017.07.05 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|